Fig. 4
Kaplan‒Meier estimates of disease progression survival in patients with relapsed or refractory HL (a) and any other tumor type except HL (b)
Fig. 4 | Signal Transduction and Targeted Therapy
Kaplan‒Meier estimates of disease progression survival in patients with relapsed or refractory HL (a) and any other tumor type except HL (b)
